肝门部胆管癌(hilar cholangiocarcinoma,HCCA)是指累及胆囊管开口及以上1/3的肝外胆管,并常扩展至肝管汇合部和一侧或双侧肝管的恶性肿瘤,其中58%~75%发生在肝胆管分叉处,又称中央型胆管癌或K latski肿瘤[1]。其发病率呈逐年上升的趋势,近年来,随着医学诊断及外科手术技术、方 Hilar cholangiocarcinoma (HCC) refers to the extrahepatic bile duct involving the opening of the cystic duct and 1/3 of the extrahepatic bile duct and often extends to the junction of the hepatic duct and malignant tumors of one or both hepatic ducts, of which 58% ~ 75% occurred in the bile duct bifurcation, also known as central cholangiocarcinoma or K latski tumor [1]. Its incidence showed a trend of rising year by year. In recent years, with the medical diagnosis and surgical techniques,